title: Priming effect of adrenic acid (22:4(n-6)) on tissue factor activity expressed by thrombin-stimulated endothelial cells.
abstract: Tissue factor (TF) which initiates clotting process can be expressed by stimulated endothelial cells (EC). TF is an apolipoprotein requiring an association with phospholipids (PL) in order to become active. Also PL constitute an important storage pool of polyunsaturated fatty acids (PUFAs) in EC which can be modulated by diet or cell medium supplementation. In order to test the effect of such manipulation upon TF activity, we have pre-enriched human EC cultures with different fatty acids of nutritional interest. TF was evaluated after 4 h of thrombin stimulation by using a chromogenic method. Without additional stimulating agents, these acids have no effect on the basal level of TF. Eicosapentaenoic and docosapentaenoic acids appeared to be ineffective at the stimulated TF level. Only adrenic acid (22:4(n-6)) has been found to significantly enhance TF activity of thrombin-stimulated endothelial cells. Other TF inducers were also tested after 22:4(n-6) enrichment. An increase tendency of TF expression was found only with tumor necrosis factor, whereas interleukin-1 beta, lipopolysaccharide and especially phorbol myristate acetate stimulations were not significantly modified. The priming effect of adrenic acid on thrombin stimulated TF expression might involve alterations of signal transduction pathways rather than modifications of apolipoprotein III environment. Adrenic acid, which is a prostacyclin inhibitor, appears to be potential prothrombotic agent.
authors.affiliation: Institut Pasteur de Lyon, INSERM U331, Laboratoire d'Hémobiologie, Faculté Alexis Carrel, France.
authors.forename: B
authors.initials: B
authors.lastname: Tardy
authors.forename: J C
authors.initials: JC
authors.lastname: Bordet
authors.forename: M
authors.initials: M
authors.lastname: Berruyer
authors.forename: P
authors.initials: P
authors.lastname: Ffrench
authors.forename: M
authors.initials: M
authors.lastname: Dechavanne
mesh_terms: D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000378:metabolism*; D004883:Erucic Acids / Q000494:pharmacology*; D005227:Fatty Acids / Q000494:pharmacology; D005231:Fatty Acids, Unsaturated; D006801:Humans; D013917:Thrombin / Q000494:pharmacology; D013925:Thromboplastin / Q000096:biosynthesis* / Q000187:drug effects
chemical_list: D004883:Erucic Acids; D005227:Fatty Acids; D005231:Fatty Acids, Unsaturated; C011395:adrenic acid; D013925:Thromboplastin; D013917:Thrombin